Skip to main content
Ipsos
  • About us
  • Investors
  • Careers
  • Contact us
Choose your market:
Ireland
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
    • Who we are
    • Our history
    • Key figures
    • Management
    • Values
    • Taking responsibility
    • Privacy & Data Protection
    • Online Data Quality Matters
  • Investors (En)
  • Careers
    • Opportunities at Ipsos
    • Professional vacancies
    • Training & Development
  • Contact us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 7 results matching with your query. Refine by
  • Society

    Ipsos B&A research for World Mental Health Day

    Ipsos, one of the world's leading market research companies, releases the fifth edition of the Ipsos World Mental Health Day report.

    10 October 2024
  • Society

    Patients’ perception and adherence regarding Methotrexate Autoinjectors for Rheumatoid Arthritis

    Rheumatoid arthritis is a chronic, inflammatory joint disease. In developed countries, it affects 0.5% to 1% of the adult population, with a two to three times higher frequency in women compared to men, regardless of age. Currently, no cure exists, however, treatments that are available worldwide can reduce progression of joint damage in up to 90% of patients.

    19 July 2021
  • Society

    National Drug and Alcohol Survey

    Ipsos MRBI has worked with HRB Ireland on the National Drug and Alcohol Survey since 2002. The latest results find that more people are using illegal stimulants, smoking less, and binge drinking remains high.

    1 July 2021
  • A year in Oncology

    A Review of 2020 Drug Approvals & Key Milestones

    19 February 2021
  • Society

    Just over half of people would get COVID-19 vaccine, says Ipsos MRBI survey for IPHA

    Just over half of people would get the COVID-19 vaccine if there was one, according to the results of a new survey by Ipsos MRBI for the Irish Pharmaceutical Healthcare Association (IPHA) which represents the international research-based biopharmaceutical industry.

    27 October 2020
  • [EVENT] World Pharma Pricing, Market Access & Evidence Congress

    March 18-19 - Ipsos is delighted to be participating in the upcoming World Pharma Pricing & Market Access Congress – Europe’s largest market access and pricing conference. We invite you to join us for a relaxed and casual dinner March 18 at 8:00 p.m., following conference cocktails.

    11 February 2020
  • New Services

    Conquering Complexity: The Coming Revolution in Oncology Biomarker Testing

    Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.

    21 June 2017

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • News & Events
  • Innovation & Knowledge
    • New Services
    • Society
  • Citizens
  • Consumers & Brands
  • Customers & Employees
  • Doctors & Patients
  • Capabilities
  • About us
  • Contact
  • Press
  • Investors
  • Careers
  • JNLR
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal Mentions
  • Privacy and Data Protection
  • Cookie policy
  • Our Alert System